Results 121 to 130 of about 123,521 (314)
Norovirus and medically attended gastroenteritis in U.S. children.
BACKGROUND Cases of rotavirus-associated acute gastroenteritis have declined since the introduction of rotavirus vaccines, but the burden of norovirus-associated acute gastroenteritis in children remains to be assessed.
D. Payne+14 more
semanticscholar +1 more source
Abstract Objectives Determining etiology for adults with symptoms of lower respiratory tract infection (LRTI) is challenging. MeMed BV (MMBV), an FDA‐cleared blood test, computationally integrates the levels of three host proteins to differentiate bacterial and viral infections.
Adam J. Singer+14 more
wiley +1 more source
Acute Gastroenteritis Hospitalizations Among US Children Following Implementation of the Rotavirus Vaccine Routine rotavirus vaccination of US children was implemented in 2006, with 2 or 3 doses recommended before the age of 8 months.1 Previous studies ...
E. Leshem+5 more
semanticscholar +1 more source
Anti‐KIT Barzolvolimab for Chronic Spontaneous Urticaria
We compared the efficacy and safety of four doses of barzolvolimab compared to placebo in reducing symptoms of chronic spontaneous urticaria in a randomized, controlled trial. Across barzolvolimab doses, rapid symptom reduction within 1 week was observed and sustained during 12 weeks.
Marcus Maurer+11 more
wiley +1 more source
Incidence of Acute Gastroenteritis and Role of Norovirus, Georgia, USA, 2004–2005
Approximately 179 million cases of acute gastroenteritis (AGE) occur annually in the United States. However, lack of routine clinical testing for viruses limits understanding of their role among persons seeking medical care. Fecal specimens submitted for
Aron J. Hall+9 more
doaj +1 more source
Intraperitoneal Fluid Infusion in Children with Gastroenteritis [PDF]
O. Ransome-Kuti+3 more
openalex +1 more source
Two Gastroenteritis Outbreaks from Ham in Picnic Fare [PDF]
J. A. Googins+3 more
openalex +1 more source
Summary Paroxysmal nocturnal haemoglobinuria (PNH) is a rare, life‐threatening disorder characterized by complement‐mediated haemolysis, leading to anaemia and thrombosis. HRS‐5965 is a novel, oral, selective complement factor B inhibitor targeting the alternative pathway, potentially reducing both intra‐ and extravascular haemolysis.
Li Zhang+7 more
wiley +1 more source
Through the ‘4As’: Awareness, Access, Advocacy, and Alliance, the Greater Bay Area will continue to leverage its unique advantages to confront ongoing challenges such as diagnostic delays and lack of access to diagnosis and hereditary angioedema (HAE)‐specific medications.
Philip H. Li+22 more
wiley +1 more source